R&D Why are eCOA studies still so challenging? Although eCOA has been in clinical trials for decades, we continue to hit the same road blocks during operational set-up and implementation.
R&D Separating scientific risk assessment & consumer perception In pharmaceutical development, conclusions are built on structured laboratory investigations and reproducible data, rather than simple classification.
R&D Changing Faces: Pharma and biotech hires, May 2026 Looking back to May, the pharma and biotech sector saw a steady stream of senior leadership changes.
R&D Parexel: Flawless execution, policy shifts & patient-centric... Parexel's Paul Bridges & Charlotte Moser discuss Europe's biotech sector in the face of an innovation cliff.
R&D Women in STEM: Overcoming exclusionary workplace culture pharmaphorum speaks with Thermo Fisher Scientific's Tina Liedtky about women in life sciences and leadership.
R&D BIOSECURE and beyond: What it really means for pharma supply... The US pharmaceutical industry is entering a new phase of supply chain transformation.
News ESMO26: Halda buy delivers a win for J&J in prostate cancer A drug at the heart of Johnson & Johnson's $3bn takeover of Halda has been shown to be "highly active" in a first-in-human prostate cancer trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
